NAUT · 10-Q · 2026Q1 · Full report

Selling, General and Administrative Expense

Nautilus Biotechnology, Inc. · 2026-04-28 · Importance 42 · Surprise 40

Selling, general and administrative (SG&A) expenses were $6.4 million for the three months ended March 31, 2026, versus $7.3 million in the comparable 2025 quarter, a decrease of $0.9 million, or 12%. The primary driver of the reduction was a $0.6 million decrease in stock-based compensation expense related to lower expense on stock options granted since the Merger. The company also realized a $0.3 million decrease in salaries and related benefits from the workforce reduction implemented in Q1 2025. SG&A declines contributed to total operating expense reduction of $2.7 million (14%) year over year.

Key facts

• Selling, general and administrative expenses were $6,417,000 for the three months ended March 31, 2026, compared to $7,308,000 for the three months ended March 31, 2025, a decrease of $891,000 or 12%.
• The decrease in selling, general and administrative expense for the three months ended March 31, 2026 was primarily due to a $0.6 million decrease in stock-based compensation and a $0.3 million decrease in salaries and related benefits.